96 related articles for article (PubMed ID: 17786725)
1. Physiological doses of cannabinoids do not adversely affect MCL viability.
Richardson SJ; Widmer M; Zajicek J; Rule SA
Leuk Lymphoma; 2007 Sep; 48(9):1855-7. PubMed ID: 17786725
[No Abstract] [Full Text] [Related]
2. WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells.
Wasik AM; Almestrand S; Wang X; Hultenby K; Dackland ÅL; Andersson P; Kimby E; Christensson B; Sander B
Cell Death Dis; 2011 Nov; 2(11):e225. PubMed ID: 22048168
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
Gustafsson K; Christensson B; Sander B; Flygare J
Mol Pharmacol; 2006 Nov; 70(5):1612-20. PubMed ID: 16936228
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma.
Flygare J; Gustafsson K; Kimby E; Christensson B; Sander B
FEBS Lett; 2005 Dec; 579(30):6885-9. PubMed ID: 16337199
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoids after cardiac arrest: should your brain be on drugs?
Tisherman SA
Crit Care Med; 2010 Dec; 38(12):2409-10. PubMed ID: 21088506
[No Abstract] [Full Text] [Related]
6. New neuron production can be increased in the hippocampus of aged rats following cannabinoid treatment.
Marchalant Y; Brothers HM; Wenk GL
Mol Psychiatry; 2009 Dec; 14(12):1067, 1068-9. PubMed ID: 19920833
[No Abstract] [Full Text] [Related]
7. Synthetic cannabinoids and endometrial stromal cell fate: Dissimilar effects of JWH-122, UR-144 and WIN55,212-2.
Fonseca BM; Fernandes R; Almada M; Santos M; Carvalho F; Teixeira NA; Correia-da-Silva G
Toxicology; 2019 Feb; 413():40-47. PubMed ID: 30502353
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
9. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
[TBL] [Abstract][Full Text] [Related]
10. Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain.
Polissidis A; Chouliara O; Galanopoulos A; Rentesi G; Dosi M; Hyphantis T; Marselos M; Papadopoulou-Daifoti Z; Nomikos GG; Spyraki C; Tzavara ET; Antoniou K
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1175-91. PubMed ID: 19941698
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoids enhance human B-cell growth at low nanomolar concentrations.
Derocq JM; Ségui M; Marchand J; Le Fur G; Casellas P
FEBS Lett; 1995 Aug; 369(2-3):177-82. PubMed ID: 7544292
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoids in the treatment of cancer.
Alexander A; Smith PF; Rosengren RJ
Cancer Lett; 2009 Nov; 285(1):6-12. PubMed ID: 19442435
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the discriminative stimulus and response rate effects of
Wiley JL; Lefever TW; Marusich JA; Craft RM
Drug Alcohol Depend; 2017 Mar; 172():51-59. PubMed ID: 28130989
[TBL] [Abstract][Full Text] [Related]
14. Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys.
Gerak LR; Zanettini C; Koek W; France CP
Psychopharmacology (Berl); 2015 Oct; 232(19):3637-47. PubMed ID: 26202613
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies.
Singh K; Jamshidi N; Zomer R; Piva TJ; Mantri N
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872551
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced in HepG2 cells by the synthetic cannabinoid WIN: involvement of the transcription factor PPARgamma.
Giuliano M; Pellerito O; Portanova P; Calvaruso G; Santulli A; De Blasio A; Vento R; Tesoriere G
Biochimie; 2009 Apr; 91(4):457-65. PubMed ID: 19059457
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development.
De Vry J; Jentzsch KR; Kuhl E; Eckel G
Behav Pharmacol; 2004 Feb; 15(1):1-12. PubMed ID: 15075621
[TBL] [Abstract][Full Text] [Related]
18. Effect of cannabinoids on platelet serotonin uptake.
Velenovská M; Fisar Z
Addict Biol; 2007 Jun; 12(2):158-66. PubMed ID: 17508987
[TBL] [Abstract][Full Text] [Related]
19. Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner.
Galanopoulos A; Polissidis A; Papadopoulou-Daifoti Z; Nomikos GG; Antoniou K
Behav Brain Res; 2011 Oct; 224(1):65-72. PubMed ID: 21645556
[TBL] [Abstract][Full Text] [Related]
20. Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells.
Giudice ED; Rinaldi L; Passarotto M; Facchinetti F; D'Arrigo A; Guiotto A; Carbonare MD; Battistin L; Leon A
J Leukoc Biol; 2007 Jun; 81(6):1512-22. PubMed ID: 17339608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
